The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice

FASEB Journal

Volumn 29, Issue 4, 2015, Pages 1540-1550

  Fagman, Johan B ^a   Wilhelmson, Anna S ^a   Motta, Benedetta M ^a   Pirazzi, Carlo ^a   Alexanderson, Camilla ^a   De Gendt, Karel ^b   Verhoeven, Guido ^b   Holmäng, Agneta ^c   Anesten, Fredrik ^c   Jansson, John Olov ^c   Levin, Malin ^a   Borén, Jan ^a   Ohlsson, Claes ^c   Krettek, Alexandra ^a,d   Romeo, Stefano ^a   Tivesten, Åsa ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

Genetically altered mice; Metabolism; Sex hormones

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; APOLIPOPROTEIN E; TRIACYLGLYCEROL; CHOLESTEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY FAT; BODY TEMPERATURE; BODY WEIGHT; CALORIMETRY; CELL CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET INDUCED OBESITY; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FATTY LIVER; FEMALE; FOOD INTAKE; GLUCOSE TOLERANCE TEST; HEPATOMA CELL; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUBERTY; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DEFICIENCY; DIET; DYSLIPIDEMIAS; GENETICS; KNOCKOUT MOUSE; LIVER; MALE; METABOLISM; OBESITY; ORCHIECTOMY; OVARIECTOMY;

MUS;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; DIET; DIHYDROTESTOSTERONE; DYSLIPIDEMIAS; FATTY LIVER; FEMALE; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; ORCHIECTOMY; OVARIECTOMY; RECEPTORS, ANDROGEN;

EID: 84931452064     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-259234     Document Type: Article

References (57)

1. Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., and Santoro, N. (2014) Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3489-3510
2. Mauvais-Jarvis, F. (2011) Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol. Metab. 22, 24-33
3. Ohlsson, C., Barrett-Connor, E., Bhasin, S., Orwoll, E., Labrie, F., Karlsson, M. K., Ljunggren, O., Vandenput, L., Mellström, D., and Tivesten, A. (2011) High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J. Am. Coll. Cardiol. 58, 1674-1681
4. Jones, T. H., and Saad, F. (2009) The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 207, 318-327
5. Bourghardt, J., Wilhelmson, A. S., Alexanderson, C., De Gendt, K., Verhoeven, G., Krettek, A., Ohlsson, C., and Tivesten, A. (2010) Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology 151, 5428-5437
6. Bhasin, S. (2005) Female androgen deficiency syndrome - an unproven hypothesis. J. Clin. Endocrinol. Metab. 90, 4970-4972
7. Braunstein, G. D. (2007) The Endocrine Society Clinical Practice Guideline and The North American Menopause Society position statement on androgen therapy in women: another one of Yogi's forks. J. Clin. Endocrinol. Metab. 92, 4091-4093
8. Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., and Dumesic, D. A. (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95, 2038-2049
9. Christakou, C. D., and Diamanti-Kandarakis, E. (2008) Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond. Engl.) 4, 583-594
10. Corbould, A. (2008) Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome? Diabetes Metab. Res. Rev. 24, 520-532
11. Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M., and Raff, H. (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J. Clin. Endocrinol. Metab. 92, 405-413
12. Liu, P. Y., Death, A. K., and Handelsman, D. J. (2003) Androgens and cardiovascular disease. Endocr. Rev. 24, 313-340
13. Walters, K. A., Simanainen, U., and Handelsman, D. J. (2010) Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Hum. Reprod. Update 16, 543-558
14. De Gendt, K., Swinnen, J. V., Saunders, P. T., Schoonjans, L., Dewerchin, M., Devos, A., Tan, K., Atanassova, N., Claessens, F., Lécureuil, C., Heyns, W., Carmeliet, P., Guillou, F., Sharpe, R. M., and Verhoeven, G. (2004) A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis. Proc. Natl. Acad. Sci. USA 101, 1327-1332
15. Lallemand, Y., Luria, V., Haffner-Krausz, R., and Lonai, P. (1998) Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase. Transgenic Res. 7, 105-112
16. Rulli, S. B., Kuorelahti, A., Karaer, O., Pelliniemi, L. J., Poutanen, M., and Huhtaniemi, I. (2002) Reproductive disturbances, pituitary lactotrope adenomas, and mammary gland tumors in transgenic female mice producing high levels of human chorionic gonadotropin. Endocrinology 143, 4084-4095
17. Purcell-Huynh, D. A., Farese, R. V., Jr., Johnson, D. F., Flynn, L. M., Pierotti, V., Newland, D. L., Linton, M. F., Sanan, D. A., and Young, S. G. (1995) Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J. Clin. Invest. 95, 2246-2257
18. Sjöberg, A., Oscarsson, J., Borén, J., Edén, S., and Olofsson, S. O. (1996) Mode of growth hormone administration influences triacylglycerol synthesis and assembly of apolipoprotein B-containing lipoproteins in cultured rat hepatocytes. J. Lipid Res. 37, 275-289
19. Pirazzi, C., Adiels, M., Burza, M. A., Mancina, R. M., Levin, M., Ståhlman, M., Taskinen, M. R., Orho-Melander, M., Perman, J., Pujia, A., Andersson, L., Maglio, C., Montalcini, T., Wiklund, O., Borén, J., and Romeo, S. (2012) Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J. Hepatol. 57, 1276-1282
20. Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S. X., and Pelletier, G. (2003) Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr. Rev. 24, 152-182
21. Hewing, B., and Fisher, E. A. (2012) Preclinical mouse models and methods for the discovery of the causes and treatments of atherosclerosis. Expert Opin Drug Discov 7, 207-216
22. Van Gaal, L. F., Mertens, I. L., and De Block, C. E. (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444, 875-880
23. Bruck, B., Brehme, U., Gugel, N., Hanke, S., Finking, G., Lutz, C., Benda, N., Schmahl, F. W., Haasis, R., and Hanke, H. (1997) Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler. Thromb. Vasc. Biol. 17, 2192-2199
24. Obasanjo, I. O., Clarkson, T. B., and Weaver, D. S. (1996) Effects of the anabolic steroid nandrolone decanoate on plasma lipids and coronary arteries of female cynomolgus macaques. Metabolism 45, 463-468
25. Adams, M. R., Williams, J. K., and Kaplan, J. R. (1995) Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler. Thromb. Vasc. Biol. 15, 562-570
26. McRobb, L., Handelsman, D. J., and Heather, A. K. (2009) Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endocrinology 150, 841-848
27. von Dehn, G., von Dehn, O., Völker, W., Langer, C., Weinbauer, G. F., Behre, H. M., Nieschlag, E., Assmann, G., and von Eckardstein, A. (2001) Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm. Metab. Res. 33, 110-114
28. Elhage, R., Arnal, J. F., Pieraggi, M. T., Duverger, N., Fiévet, C., Faye, J. C., and Bayard, F. (1997) 17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 17, 2679-2684
29. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., and Ross, R. (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14, 133-140
30. van Vlijmen, B. J., van 't Hof, H. B., Mol, M. J., van der Boom, H., van der Zee, A., Frants, R. R., Hofker, M. H., and Havekes, L. M. (1996) Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 97, 1184-1192
31. Chiuve, S. E., Martin, L. A., Campos, H., and Sacks, F. M. (2004) Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women. J. Clin. Endocrinol. Metab. 89, 2207-2213
32. Wang, X., Magkos, F., and Mittendorfer, B. (2011) Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J. Clin. Endocrinol. Metab. 96, 885-893
33. Zhang, H., Liu, Y., Wang, L., Li, Z., Zhang, H., Wu, J., Rahman, N., Guo, Y., Li, D., Li, N., Huhtaniemi, I., Tsang, S. Y., Gao, G. F., and Li, X. (2013) Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J. Lipid Res. 54, 345-357
34. Strong, A., and Rader, D. J. (2012) Sortilin as a regulator of lipoprotein metabolism. Curr. Atheroscler. Rep. 14, 211-218
35. Jo, H., Choe, S. S., Shin, K. C., Jang, H., Lee, J. H., Seong, J. K., Back, S. H., and Kim, J. B. (2013) Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor. Hepatology 57, 1366-1377
36. Huff, M. W., and Hegele, R. A. (2013) Apolipoprotein C-III: going back to the future for a lipid drug target. Circ. Res. 112, 1405-1408
37. Graham, M. J., Lee, R. G., Bell III, T. A., Fu, W., Mullick, A. E., Alexander, V. J., Singleton, W., Viney, N., Geary, R., Su, J., Baker, B. F., Burkey, J., Crooke, S. T., and Crooke, R. M. (2013) Antisense oligonucleotide inhibition of apolipoprotein C-III reduces plasma triglycerides in rodents, nonhuman primates, and humans. Circ. Res. 112, 1479-1490
38. Fan, W., Yanase, T., Nomura, M., Okabe, T., Goto, K., Sato, T., Kawano, H., Kato, S., and Nawata, H. (2005) Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 54, 1000-1008
39. Lin, H. Y., Xu, Q., Yeh, S., Wang, R. S., Sparks, J. D., and Chang, C. (2005) Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. Diabetes 54, 1717-1725
40. Shiina, H., Matsumoto, T., Sato, T., Igarashi, K., Miyamoto, J., Takemasa, S., Sakari, M., Takada, I., Nakamura, T., Metzger, D., Chambon, P., Kanno, J., Yoshikawa, H., and Kato, S. (2006) Premature ovarian failure in androgen receptor-deficient mice. Proc. Natl. Acad. Sci. USA 103, 224-229
41. Yeh, S., Hu, Y. C., Wang, P. H., Xie, C., Xu, Q., Tsai, M. Y., Dong, Z., Wang, R. S., Lee, T. H., and Chang, C. (2003) Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. J. Exp. Med. 198, 1899-1908
42. Walters, K. A., Allan, C. M., Jimenez, M., Lim, P. R., Davey, R. A., Zajac, J. D., Illingworth, P., and Handelsman, D. J. (2007) Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility. Endocrinology 148, 3674-3684
43. Kawano, H., Sato, T., Yamada, T., Matsumoto, T., Sekine, K., Watanabe,T.,Nakamura,T.,Fukuda,T.,Yoshimura,K.,Yoshizawa, T., Aihara, K., Yamamoto, Y., Nakamichi, Y., Metzger, D., Chambon, P., Nakamura, K., Kawaguchi, H., and Kato, S. (2003) Suppressive function of androgen receptor in bone resorption. Proc. Natl. Acad. Sci. USA 100, 9416-9421
44. Lin, H. Y., Yu, I. C., Wang, R. S., Chen, Y. T., Liu, N. C., Altuwaijri, S., Hsu, C. L., Ma, W. L., Jokinen, J., Sparks, J. D., Yeh, S., and Chang, C. (2008) Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 47, 1924-1935
45. O'Reilly, M. W., House, P. J., and Tomlinson, J. W. (2014) Understanding androgen action in adipose tissue. J. Steroid Biochem. Mol. Biol. 143, 277-284
46. McInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T., Andrew, R., and Walker, B. R. (2012) Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis. Diabetes 61, 1072-1081
47. Yu, I. C., Lin, H. Y., Liu, N. C., Wang, R. S., Sparks, J. D., Yeh, S., and Chang, C. (2008) Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology 149, 2361-2368
48. Veldhuis, J. D., and Dufau, M. L. (1993) Steroidal regulation of biologically active luteinizing hormone secretion in men and women. Hum. Reprod. 8(Suppl 2), 84-96
49. Nestler, J. E. (2008) Metformin for the treatment of the polycystic ovary syndrome. N. Engl. J. Med. 358, 47-54
50. Bernini, G. P., Sgro', M., Moretti, A., Argenio, G. F., Barlascini, C. O., Cristofani, R., and Salvetti, A. (1999) Endogenous androgens and carotid intimal-medial thickness in women. J. Clin. Endocrinol. Metab. 84, 2008-2012
51. Golden, S. H., Maguire, A., Ding, J., Crouse, J. R., Cauley, J. A., Zacur, H., and Szklo, M. (2002) Endogenous postmenopausal hormones and carotid atherosclerosis: a case-control study of the atherosclerosis risk in communities cohort. Am. J. Epidemiol. 155, 437-445
52. Kaczmarek, A., Reczuch, K., Majda, J., Banasiak, W., and Ponikowski, P. (2003) The association of lower testosterone level with coronary artery disease in postmenopausal women. Int. J. Cardiol. 87, 53-57
53. Montalcini, T., Gorgone, G., Gazzaruso, C., Sesti, G., Perticone, F., and Pujia, A. (2007) Role of endogenous androgens on carotid atherosclerosis in non-obese postmenopausal women. Nutr. Metab. Cardiovasc. Dis. 17, 705-711
54. Laughlin, G. A., Goodell, V., and Barrett-Connor, E. (2010) Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J. Clin. Endocrinol. Metab. 95, 740-747
55. Patel, S. M., Ratcliffe, S. J., Reilly, M. P., Weinstein, R., Bhasin, S., Blackman, M. R., Cauley, J. A., Sutton-Tyrrell, K., Robbins, J., Fried, L. P., and Cappola, A. R. (2009) Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 94, 4776-4784
56. Sievers, C., Klotsche, J., Pieper, L., Schneider, H. J., März, W., Wittchen, H. U., Stalla, G. K., and Mantzoros, C. (2010) Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur. J. Endocrinol. 163, 699-708
57. Manolakou, P., Angelopoulou, R., Bakoyiannis, C., and Bastounis, E. (2009) The effects of endogenous and exogenous androgens on cardiovascular disease risk factors and progression. Reprod. Biol. Endocrinol. 7, 44